Key result
A clinical pharmacist-managed anticoagulation clinic reduced hospitalization days from 3.22 to 0.048 per patient-treatment-year compared to control, with a benefit:cost ratio of 6.55.
Why the study?
Does a clinical pharmacist-managed anticoagulation clinic improve therapeutic prothrombin times and reduce hospitalizations and costs in patients requiring anticoagulation?
Cohort (n=52)
Does a clinical pharmacist-managed anticoagulation clinic improve therapeutic prothrombin times and reduce hospitalizations and costs in patients requiring anticoagulation?
A clinical pharmacist-managed anticoagulation clinic is highly cost-effective, significantly improving time in therapeutic range and reducing hospitalizations for bleeding and thromboembolism.
Answers are grounded in this paper and cite their sources.
May support pharmacist-managed anticoagulation clinics; leaves open need for randomized confirmation.
A cost-benefit evaluation of a clinical pharmacist-managed anticoagulation clinic (AC) was performed. Outpatient and hospital records were examined for 26 patients in the treatment group with an AC clinic and 26 patients in the control group. Therapeutic prothrombin times were maintained within the treatment group to a significantly greater extent than within the control group (p<0.001). The AC was successful in preventing hospitalizations resulting from hemorrhage or thromboembolic admissions (p<0.05, p<0.005, respectively). Patients were hospitalized 3.22 days and .048 days per patient-treatment-year in the control and treatment groups, respectively. The net savings in reduced hospitalization costs per year in the treatment group was $211,776. The benefit:cost ratio (B:C) was 6.55, suggesting the program is socially valuable. This clinical pharmacist-managed AC was effective in maintaining therapeutic prothrombin times, and reducing the incidence of hospitalizations resulting from anticoagulation complications, and can be cost-justified based on a cost-benefit analysis.
No takes yet. Share an insight, caveat, or question.
Gray et al. (2007) conducted a cohort in Anticoagulation therapy (n=52). Clinical pharmacist-managed anticoagulation clinic (AC) vs. Control group was evaluated on Hospitalization days per patient-treatment-year. A clinical pharmacist-managed anticoagulation clinic reduced hospitalization days from 3.22 to 0.048 per patient-treatment-year compared to control, with a benefit:cost ratio of 6.55.
Synapse has enriched 10 related papers. Consider them for comparative context: